SUMMARY The effects of a porcine gastric fundic mucosal extract (molecular weight <10 000) has been compared with the effects of eight candidate gastrointestinal peptides on glucose absorption from the jejunum in a rat model. Bolus injection of the extract produced immediate and marked depression of glucose absorption. None of the candidate peptides tested produced this response, although somatostatin and substance P depressed absorption as a late phenomenon after 30 minutes. We conclude that the effects of the fundic extract are not reproduced by any of these candidate peptides. This strengthens the evidence for a novel gastrointestinal peptide, resident in fundic mucosa, which affects absorption from upper small bowel.
There is evidence for a peptide factor, secreted from gastric fundic mucosa, which affects jejunal mucosal absorption. 1-4 Stimulation of gastric fundic mucosa by distension or raised pH significantly reduced luminal loss of glucose, 14C-labelled 3-0-methyl glucose and tracer ions 22Na and 99mTc, from the jejunum. An extract of porcine gastric mucosa also reduced jejunal absorption when infused intravenously in a rat model. 4 Samples of the porcine gastric fundic mucosal extract contained only small and variable amounts of some of the known gastrointestinal peptides (Bloom, personal communication; Table 1 ). The present series of experiments was designed to see if the effects of the fundic extract on jejunal absorption could be because of the action of a specific candidate gastrointestinal peptide.
Methods
Pure synthetic peptides (Table 2) were dissolved in distilled water in siliconised containers and dilutions prepared with 1% bovine albumin (Sigma Chemical Co.) in 015M saline. Aliquots were taken and kept Requests for reprints: Mr J B Elder, University Department of Surgery.
Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL. Received for publication 19 July 1982 at -20°C until used. Candidate peptides were selected according to their known distribution in the gastric mucosa or their identification in the crude porcine gastric fundic extract. In previous experiments porcine gastric fundic extract has been administered by constant intravenous infusion. ' In the present series, however, the extract, and each candidate peptide, was given by a single bolus injection to allow observation of the time course of any effect. As each peptide dose was given by bolus injection dilution would occur, initially in the rat blood volume (10-12 ml) and later, almost certainly in a larger theoretical volume of distribution. It is, therefore, likely that effective concentrations were obtained of a smaller order of magnitude than the initial bolus dose. This technique was used in order to allow several peptides to be tested over a wide dose range, and to permit comparison with the effects of the unknown concentration of active agent in the gastric fundic extract. Fundic extract was prepared from gastric fundic mucosa dissected from fresh pig stomachs as described elsewhere. ' In essence, the method consisted of extracting lyophilised, acetoneextracted fundic mucosa with water at 80°C. The aqueous extract was mixed with an equal volume of absolute ethanol, centrifuged, and the supernatant lyophilised to produce a powder designated as 'crude extract'.
The crude extract was dissolved in water and passed through an Amicon filter with a cut-off point molecular weight <10 000, and freeze dried. One hundred and seventy-two rats were used in all. Fifty-four received albumin/saline with no peptide and acted as controls; 12 received the porcine gastric fundic extract, 10 somatostatin, eight substance P, 12 glucagon, 12 neurotensin, 12 bombesin, 14 VIP, 20 motilin, and 18 pentagastrin. The perfused bowel segments measured 9.9 cm on average for both control and peptide groups.
Results
Mean glucose luminal losses for each peptide are compared with control groups in Figs 2-10. Data for pentagastrin and motilin appear with their own relevant controls because these experiments were performed separately from the others.
The porcine fundic mucosal extract, injected at a concentration of 30 mg % protein, reduced glucose absorption by 22.7% in the first 15 minutes (p<0.0125, n=6 (Fig. 2) ). This effect was sustained up to 30 minutes but thereafter the rate of absorption was the same as in the control group. Fundic extract injected at a concentration of 300 mg % protein reduced glucose absorption throughout the hour; by 48% in the first 15 minutes (p<0.001, n=6), by 8% from 15-30 minutes, and by 21% from 30-60 minutes (p<0.005). Overall reduction of absorption over the 60 minute period was 22.3% (p<0.00l).
The various doses of somatostatin had no obvious effect on jejunal glucose absorption in the first 30 minutes (Fig. 3) . Glucose absorption at 60 minutes does not differ significantly from controls, but on comparison with the gradients for the 30-60 minute period somatostatin 100 ng and 1000 ng reduced glucose absorption by 36% (p<0.002, n=4) and 43% (p<0.001, n=6) respectively.
Substance P 100 ng produced no significant change in glucose absorption but 1000 ng reduced absorption by 20.2% (p<0.001, n=4 (Fig. 4) Glucagon 100 ng produced no significant effect on glucose absorption (Fig. 5) . One thousand nanograms glucagon increased jejunal absorption by 19% from 30-60 minutes (p<001, n=4) but the effect was not significant over the whole hour. Ten thousand nanograms glucagon increased absorption by 53% from 15-30 minutes (p<0.002, n=4) and by 30% from 30-60 minutes (p<002), an increase over the whole 60 minute period of 28.5% (p<0.001). Fig. 4 Glucose (,mol) luminal loss after injection of substance P 100 ng and 1000 nglrat. ***p<0.001. Neurotensin 10 ng and 1000 ng produced near control rates of glucose absorption (Fig. 6) , neurotensin 100 ng produced a 14% increase in absorption over 60 minutes (p<0O02, n=4 (Fig. 6) Effects of candidate peptides on jejunal glucose absorption in the rat 331 substance P detected in the extract was 32.2 ng/ml whereas it required 1000 ng of the pure peptide to produce any significant effect on absorption in the rat model.
Our results suggest that the biological effect is not due to the action of any single peptide tested in the present study. These observations strengthen our hypothesis that the responsible factor is a novel peptide released from the gastric fundic mucosa. Any theories concerning possible physiological actions of a gastric fundic factor must remain speculative until more is known about its chemistry, distribution, and actions. As the\detection of the factor depends, for the present, upon its effect on small bowel absorption it may be that the factor is involved in the regulation of absorption just as other gastrointestinal peptides contribute to the neuroendocrine control of the other gut functions of secretion, digestion and motility. Some delay in absorption from upper small bowel may help to prevent too rapid a rise in blood glucose which could produce a large output of insulin resulting in hypoglycaemia if absorption is completed abruptly. This phenomenon is well recognised as a complication of gastric surgery.
Debnam reported that perfusion of rat terminal ileum with monosaccharide solutions markedly increased jejunal absorption of tracer substances.13
It is known that L-cells occur most densely in the mucosa of the terminal ileum and caecum. 12
Furthermore, L-cells are known to release enteroglucagon when exposed to sugars, amino acids, and food residues in the bowel lumen.14 It is, therefore, possible that the phenomenon described by Debnam depends upon the release of enteroglucagon and that this may form part of a mechanism controlling the rate of absorption in the jejunum according to the concentration of unabsorbed products of digestion reaching the terminal ileum."
Poulakos and Kent reported that marker substances rapidly passed through upper small bowel in the rat.'6 If the animals were fasted before observations were made, the leading edge of the marker moved significantly faster, traversing 75% of the small bowel length in 15 minutes. Read et al observed rates of food transit through the bowel in conscious human subjects using marker dyes, radioactive particles and measuring breath hydrogen concentration as oligosaccharides in the meal were degraded by colonic bacteria. They recorded an early peak in breath hydrogen concentration within 30 minutes of food ingestion with a larger peak some hours later. 17 The early peak in their data is consistant with the arrival of a small sample of the test meal in the distal bowel within 30 minutes of eating.
Thus one may speculate that food, by distension of the stomach and buffering of its acid, would stimulate release of gastric fundic factor. The factor would act to inhibit absorption during the passage of gastric chyme through the jejunum to the terminal ileum. The presence of chyme in the terminal ileum would stimulate enteroglucagon release and so prepare the jejunum to absorb the digested products of the main bulk of the meal. So, it is possible that gastric fundic factor and enteroglucagon, together with other factors may serve to regulate the rate and distribution of absorption along the small bowel.
* This work was reported in preliminary form as a paper to the BSG meeting April 1981 at Bristol.
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A short bibliography groups the major standard texts according to discipline and refers to more general texts and review articles. The atlas ends with a simple clear index. It is a work which will prove invaluable to the diagnostic histopathologist, and should amply succeed in its intention of extending his experience. 
